Cargando...
Targeting Gastrin-Releasing Peptide as a New Approach to Treat Aggressive Refractory Neuroblastomas
BACKGROUND: The overall survival for neuroblastoma remains dismal, largely in part, due to emergence of resistance to chemotherapeutic drugs. We have demonstrated that gastrin-releasing peptide (GRP), a gut peptide secreted by neuroblastoma, act as an autocrine growth factor. We hypothesized that kn...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2010
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3668794/ https://ncbi.nlm.nih.gov/pubmed/21035156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.surg.2010.08.011 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|